首页> 外文OA文献 >Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?

【2h】

Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?

机译：绝对淋巴细胞计数与晚期乳腺癌患者的转移位点增加肿瘤浸润性淋巴细胞之间是否有任何关联的患者，这些乳腺蛋白患者从伊吡林治疗中受益？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kadri Altundag;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Absolute lymphocyte count (ALC) is a predictor of eribulin benefit in advanced or metastatic breast cancer (MBC) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：绝对淋巴细胞计数（ALC）是在先进或转移性乳腺癌（MBC）中的Eribulin受益的预测因子
2. Survival benefit of eribulin for metastatic breast cancer depends on absolute lymphocyte count and neutrophil-lymphocyte ratio in peripheral blood [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：Eribulin用于转移性乳腺癌的生存益处取决于外周血中的绝对淋巴细胞计数和中性粒细胞淋巴细胞比
3. Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel [J] . Miyagawa Yoshimasa, Araki Kazuhiro, Bun Ayako, Clinical breast cancer . 2018,第5期

机译：低基线中性粒细胞对淋巴细胞比率和患者患者的患者的无进展存活率之间的显着关联，纤维蛋白治疗但不用Nab-PACLITAXEL
4. Recognition of Non-synonymous Somatic Mutations by Tumor Infiltrating Lymphocytes (TIL) in Metastatic Breast Cancer [C] . Nikos Zacharakis International Symposium on Mathematical and Computational Oncology . 2019

机译：转移性乳腺癌中肿瘤浸润淋巴细胞（TIL）的非同义体细胞突变的识别。
5. An increase in the frequency of hprt mutant T lymphocytes in the peripheral blood, synovial fluid, and synovial tissue of rheumatoid arthritis patients. [D] . Cannons, Jennifer. 1997

机译：类风湿性关节炎患者外周血，滑液和滑膜组织中hprt突变T淋巴细胞的频率增加。
6. High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study [O] . Yasuo Miyoshi, Yuta Yoshimura, Kenichi Saito, -1

机译：在EMBRACE研究中高绝对淋巴细胞计数与接受eribulin治疗但不与医生选择的治疗相关的转移性乳腺癌患者的总体生存期更长
7. Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer. [O] . Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, 2017

机译：使用肿瘤浸润淋巴细胞（TILs）预测乳腺癌中艾日布林化疗的治疗反应。
8. Visualizing Breast Cancer Cell Interaction With Tumor-Infiltrating Lymphocytes During Immunotherapy [R] . Beuneu, H, Demaria, S, Dustin, M, 2014

机译：在免疫治疗期间可视化乳腺癌细胞与肿瘤浸润淋巴细胞的相互作用

Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?

著录项

引文网络

相似文献

相关主题

期刊订阅